Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma

Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.10808-10809
Hauptverfasser: Fu, Yu-Hua, Wu, Shang-Ju, Tan, Elise Chia-Hui, Wang, Chi-Chuan, Kim, Kibum, Chou, Wen-Chien, Lin, Fang-Ju
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10809
container_issue Supplement 1
container_start_page 10808
container_title Blood
container_volume 140
creator Fu, Yu-Hua
Wu, Shang-Ju
Tan, Elise Chia-Hui
Wang, Chi-Chuan
Kim, Kibum
Chou, Wen-Chien
Lin, Fang-Ju
description
doi_str_mv 10.1182/blood-2022-162980
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_162980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122064163</els_id><sourcerecordid>S0006497122064163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1850-4eab9bed61350478bb4d81ab0b776fcecd48b819b727f1b9a82a9c118c5d20463</originalsourceid><addsrcrecordid>eNp90M1KAzEQwPEgCtbqA3jLC0STdD-yeKprq8KCHqrXJR8TG9ndlCSt1Kd3az0LA3P6D8MPoWtGbxgT_FZ13hvCKeeEFbwS9ARNWM4FoZTTUzShlBYkq0p2ji5i_KSUZTOeT1BX-5jIwlrQye1ggBjxfJDdPrqIvcXL4IfUuQHwKoBMPQwJf7m0xq--k2n7ve2lwu9gfHIDHufBWbuNgBsZPgDfkxq6Djf7frP2vbxEZ1Z2Ea7-9hS9LRer-ok0L4_P9bwhmomckgykqhSYgs1ympVCqcwIJhVVZVlYDdpkQglWqZKXlqlKCi4rPTLo3HCaFbMpYse7OvgYA9h2E1wvw75ltD1wtb9c7YGrPXKNzd2xgfGxnYPQRu1g0GBcGG1a490_9Q_mknRi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fu, Yu-Hua ; Wu, Shang-Ju ; Tan, Elise Chia-Hui ; Wang, Chi-Chuan ; Kim, Kibum ; Chou, Wen-Chien ; Lin, Fang-Ju</creator><creatorcontrib>Fu, Yu-Hua ; Wu, Shang-Ju ; Tan, Elise Chia-Hui ; Wang, Chi-Chuan ; Kim, Kibum ; Chou, Wen-Chien ; Lin, Fang-Ju</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-162980</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.10808-10809</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1850-4eab9bed61350478bb4d81ab0b776fcecd48b819b727f1b9a82a9c118c5d20463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Fu, Yu-Hua</creatorcontrib><creatorcontrib>Wu, Shang-Ju</creatorcontrib><creatorcontrib>Tan, Elise Chia-Hui</creatorcontrib><creatorcontrib>Wang, Chi-Chuan</creatorcontrib><creatorcontrib>Kim, Kibum</creatorcontrib><creatorcontrib>Chou, Wen-Chien</creatorcontrib><creatorcontrib>Lin, Fang-Ju</creatorcontrib><title>Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp90M1KAzEQwPEgCtbqA3jLC0STdD-yeKprq8KCHqrXJR8TG9ndlCSt1Kd3az0LA3P6D8MPoWtGbxgT_FZ13hvCKeeEFbwS9ARNWM4FoZTTUzShlBYkq0p2ji5i_KSUZTOeT1BX-5jIwlrQye1ggBjxfJDdPrqIvcXL4IfUuQHwKoBMPQwJf7m0xq--k2n7ve2lwu9gfHIDHufBWbuNgBsZPgDfkxq6Djf7frP2vbxEZ1Z2Ea7-9hS9LRer-ok0L4_P9bwhmomckgykqhSYgs1ympVCqcwIJhVVZVlYDdpkQglWqZKXlqlKCi4rPTLo3HCaFbMpYse7OvgYA9h2E1wvw75ltD1wtb9c7YGrPXKNzd2xgfGxnYPQRu1g0GBcGG1a490_9Q_mknRi</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Fu, Yu-Hua</creator><creator>Wu, Shang-Ju</creator><creator>Tan, Elise Chia-Hui</creator><creator>Wang, Chi-Chuan</creator><creator>Kim, Kibum</creator><creator>Chou, Wen-Chien</creator><creator>Lin, Fang-Ju</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma</title><author>Fu, Yu-Hua ; Wu, Shang-Ju ; Tan, Elise Chia-Hui ; Wang, Chi-Chuan ; Kim, Kibum ; Chou, Wen-Chien ; Lin, Fang-Ju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1850-4eab9bed61350478bb4d81ab0b776fcecd48b819b727f1b9a82a9c118c5d20463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Yu-Hua</creatorcontrib><creatorcontrib>Wu, Shang-Ju</creatorcontrib><creatorcontrib>Tan, Elise Chia-Hui</creatorcontrib><creatorcontrib>Wang, Chi-Chuan</creatorcontrib><creatorcontrib>Kim, Kibum</creatorcontrib><creatorcontrib>Chou, Wen-Chien</creatorcontrib><creatorcontrib>Lin, Fang-Ju</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fu, Yu-Hua</au><au>Wu, Shang-Ju</au><au>Tan, Elise Chia-Hui</au><au>Wang, Chi-Chuan</au><au>Kim, Kibum</au><au>Chou, Wen-Chien</au><au>Lin, Fang-Ju</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>10808</spage><epage>10809</epage><pages>10808-10809</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-162980</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.10808-10809
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_162980
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Cost-Effectiveness Analysis of Frontline Treatment with Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T06%3A28%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-Effectiveness%20Analysis%20of%20Frontline%20Treatment%20with%20Polatuzumab%20Vedotin%20in%20Diffuse%20Large%20B-Cell%20Lymphoma&rft.jtitle=Blood&rft.au=Fu,%20Yu-Hua&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=10808&rft.epage=10809&rft.pages=10808-10809&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-162980&rft_dat=%3Celsevier_cross%3ES0006497122064163%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122064163&rfr_iscdi=true